Quality of Life After Ministernotomy Versus Full Sternotomy Aortic Valve Replacement (QUALITY-AVR)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02726087 |
|
Recruitment Status :
Recruiting
First Posted : April 1, 2016
Last Update Posted : February 15, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Aortic Valve Stenosis Heart Valve Diseases Aortic Valve Disease | Procedure: ministernotomy Procedure: Full sternotomy | Not Applicable |
This is a single-center, single-blind, all comer, randomized controlled trial. Patients scheduled for isolated aortic valve replacement (AVR) due to aortic stenosis at "Virgen de la Victoria Universitary Hospital", Málaga, Spain, will be eligible. Ninety-six patients will be randomly assigned to either partial upper sternotomy (ministernotomy, 48 patients) or full sternotomy AVR (48 patients). Sample size was determined for an Alpha error of 0.05,and Beta error of 0.1 for a power of 90% in detecting 0.10 difference points in quality of life EQ-5D-5L-index or 10 points in EQ-5D-5L-Visual Analogic Scale.
Inclusion criteria is severe aortic stenosis referred for medically indicated isolated aortic valve replacement due to aortic stenosis in patients >18 years.
Exclusion criteria are left ventricular ejection fraction less than 40%, previous cardiac surgery, urgent/emergent surgery, infective endocarditis, need of concomitant procedures other than isolated Morrow miectomy and thorax deformity.
CE-marked and FDA-approved mechanical (Sorin Carbomedics®) and stented bioprosthetic aortic valves will be implanted (Carpentier Edwards Perimount® and Sorin Crown®). Perceval S Sutureless bioprosthetic valves (LivaNova®) could be used if needed in very small aortic annulus or high risk patients Quality of Life postoperative outcomes will be assessed, as QOL measurements and health status with the EQ-5D-5L® questionnaire (QOL index, health visual analogic scale, severity index and health index), repeatedly assessed preoperatively and postoperatively at 1-6-12 months. Clinical postoperative complications and outcomes will be registered at 1 month and 1 year as main secondary and safety end-point (combined end-point of 4 and 6 major complications) Patient Satisfaction will be assessed with a 20 question cardiac-surgery specific satisfaction questionnaire (SATISCORE®).
Survival will be assessed at 1 year. Clinical pre and postoperative characteristics will be registered. Routine blood sampling will be performed pre- and postoperatively. All available data will be collected prospectively. Informed consent) will be obtained from patients meeting the inclusion criteria before the initiation of any study-specific procedures.
The Institutional Review Board Ethic Comittee approved this study.
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 96 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Participant) |
| Primary Purpose: | Treatment |
| Official Title: | Health-related Quality of Life, Satisfaction and Outcomes After Ministernotomy Versus Full Sternotomy Aortic Valve Replacement. A Randomized Controlled Trial (QUALITY-AVR TRIAL) |
| Study Start Date : | March 20, 2016 |
| Estimated Primary Completion Date : | May 20, 2019 |
| Estimated Study Completion Date : | May 20, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: ministernotomy
Minimally invasive aortic valve replacement with Partial "J" upper hemisternotomy through right 4th intercostal space, performed according to current standard of care practice.
|
Procedure: ministernotomy
Partial upper "J" hemisternotomy trough 4th right intercostal space) |
|
Active Comparator: full sternotomy
Full sternotomy AVR through a standard median sternotomy, performed according to current standard of care practice.
|
Procedure: Full sternotomy
Conventional full median sternotomy |
- Differences between intervention groups in change from baseline Questionnaire EQ-5D-5L® Index at 1, 6 or 12 months [ Time Frame: baseline-1-6-12 months ]Questionnaire EQ-5D-5L® for quality of life
- Differences between intervention groups in change from baseline Questionnaire EQ-5D-5L® Visual Analogic Scale for pain at 1, 6 or 12 months [ Time Frame: baseline-1-6-12 months ]Questionnaire EQ-5D-5L® for quality of life
- Early postoperative combined endpoint of 6 complications [ Time Frame: 1 month ]All cause Mortality, acute myocardial infarction, cerebrovascular or transient ischemic accident, acute renal failure AKIN (acute kidney injury classification) greater or equal than 2, nosocomial infections (Pneumonia, early endocarditis, mediastinitis, sepsis) and need of any reintervention
- Satiscore Questionnaire [ Time Frame: 1-6 months ]Satisfaction in cardiac surgery
- Differences between intervention groups in change from baseline Questionnaire EQ-5D-5L® severity index at 1, 6 and 12 months [ Time Frame: baseline-1-6-12 months ]Questionnaire EQ-5D-5L® for quality of life
- Differences between intervention groups in change from baseline Questionnaire EQ-5D-5L® health index (severity index inverse) at 1, 6 and 12 months [ Time Frame: baseline-1-6-12 months ]Questionnaire EQ-5D-5L® for quality of life
- Late postoperative combined endpoint of 6 complications [ Time Frame: 1-5 years ]All cause Mortality, acute myocardial infarction, cerebrovascular or transient ischemic accident, acute renal failure AKIN (acute kidney injury classification) greater or equal than 2, nosocomial infections (Pneumonia, early endocarditis, mediastinitis, sepsis) and need of any reintervention
- Total in-Hospital and Intensive Care Unit stay (in days) [ Time Frame: From date of surgery until the date of discharge or date of death from any cause, whichever came first, assessed up to 1 year ]
- Cardiopulmonary bypass time in minutes and cross-clamp ischemic heart time in minutes needed in the surgery [ Time Frame: day 1 after surgery ]
- Mechanical Ventilatory Support time needed after surgery (in hours) [ Time Frame: 7 days ]
- Transfusional requirements (number of red packed cells, fresh frozen plasma and platelets) [ Time Frame: First 72 hours after surgery ]
- New York Heart Association functional class scale for heart failure [ Time Frame: baseline-1-6-12 months ]To assess heart failure status between participants
- Number of participants alive (Survival) [ Time Frame: 6-12 months ]To assess first year mortality
- Number of participants alive (Survival) [ Time Frame: 5 years ]To assess 5 year mortality
- Early postoperative combined endpoint of 4 complications [ Time Frame: 1 month ]All cause Mortality, acute myocardial infarction, cerebrovascular or transient ischemic accident, and acute renal failure AKIN (acute kidney injury classification) greater or equal than 2,
- Late postoperative combined endpoint of 4 complications [ Time Frame: 1-5 years year ]All cause Mortality, acute myocardial infarction, cerebrovascular or transient ischemic accident, and acute renal failure AKIN (acute kidney injury classification) greater or equal than 2,
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- ≥ 18 years of age
- Severe aortic stenosis defined as aortic valve area of less than 1 cm2 or index area of 0.6 cm2/m2 or mean gradient greater than 40 mmHg by echocardiography or double lesion with predominant stenosis.
- Referred for medically indicated aortic valve replacement
- Provide written informed consent
Exclusion Criteria:
- Left ventricular ejection fraction less than 0.40
- Presence of any coexisting severe valvular disorder
- Previous cardiac surgery
- Urgent or emergent surgery
- Infective endocarditis
- Need for concomitant procedures other than isolated myectomy
- Severe COPD
- Severe thorax deformity.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02726087
| Contact: Emiliano A Rodriguez-Caulo, MD,PhD,FECTS | +34 951032054 | erodriguezcaulo@hotmail.com |
| Spain | |
| Hospital Universitario Virgen de La Victoria | Recruiting |
| Malaga, Spain, 29010 | |
| Contact: Emiliano A Rodriguez-Caulo, MD,PhD,FETCS +34 951032054 erodriguezcaulo@hotmail.com | |
| Principal Investigator: Emiliano A Rodríguez-Caulo, MD,PhD,FETCS | |
| Sub-Investigator: Juan Otero, MD, PhD | |
| Sub-Investigator: María José Mataró, MD, PhD | |
| Sub-Investigator: Gemma Sánchez-Espín, MD, PhD | |
| Sub-Investigator: Carlos Porras, MD | |
| Sub-Investigator: Miguel Such, MD,PhD,FETCS | |
| Sub-Investigator: Ana Guijarro, MD | |
| Sub-Investigator: José María Melero, MD, FETCS | |
| Sub-Investigator: José M Villaescusa, MD | |
| Sub-Investigator: Begoña Vidal, MD | |
| Principal Investigator: | Emiliano A Rodriguez-Caulo, MD,PhD,FECTS | Hospital Universitario Virgen de la Victoria, Málaga, spain |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Emiliano Rodriguez-Caulo, MD, PhD, FETCS, Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud |
| ClinicalTrials.gov Identifier: | NCT02726087 History of Changes |
| Other Study ID Numbers: |
CALIDAD-SVAO |
| First Posted: | April 1, 2016 Key Record Dates |
| Last Update Posted: | February 15, 2019 |
| Last Verified: | February 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
|
Ministernotomy aortic valve stenosis quality of life satisfaction cardiac surgery |
|
Aortic Valve Stenosis Heart Valve Diseases Heart Diseases Cardiovascular Diseases Ventricular Outflow Obstruction |